Insider Selling: Phreesia, Inc. (NYSE:PHR) General Counsel Sells $180,158.88 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 6,556 shares of the firm’s stock in a transaction dated Monday, January 27th. The stock was sold at an average price of $27.48, for a total value of $180,158.88. Following the sale, the general counsel now directly owns 152,361 shares of the company’s stock, valued at $4,186,880.28. The trade was a 4.13 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Phreesia Stock Down 1.8 %

Shares of NYSE:PHR opened at $28.47 on Friday. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $29.90. The firm’s 50 day moving average price is $24.98 and its 200 day moving average price is $23.28. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a market cap of $1.65 billion, a price-to-earnings ratio of -19.37 and a beta of 0.94.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company’s revenue was up 16.6% on a year-over-year basis. During the same period last year, the business earned ($0.58) EPS. As a group, equities research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in PHR. Hsbc Holdings PLC purchased a new stake in Phreesia during the second quarter worth approximately $301,000. Sei Investments Co. raised its holdings in Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares in the last quarter. Squarepoint Ops LLC lifted its position in shares of Phreesia by 56.3% during the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock worth $5,308,000 after buying an additional 90,215 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Phreesia in the 3rd quarter valued at $954,000. Finally, Diversified Trust Co grew its position in shares of Phreesia by 12.9% in the 3rd quarter. Diversified Trust Co now owns 24,356 shares of the company’s stock valued at $555,000 after buying an additional 2,782 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on PHR. KeyCorp lifted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. JMP Securities reissued a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Piper Sandler restated an “overweight” rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a research report on Wednesday. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, Truist Financial raised their target price on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Thirteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $31.15.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.